Table 1.
Baseline demographics of participants
| Baseline characteristics | Control period | RBVM period |
|---|---|---|
| All Participants (count) | (n = 161) | (n = 167) |
| Age (yrs) | 56.9±15.0 | 56.2±15.0 |
| Female N (%) | 66 (41.0) | 68 (41.0) |
| Race/Ethnicity N (%) | ||
| White | 82 (50.9) | 86 (51.5) |
| Black | 38 (23.6) | 42 (25.2) |
| Hispanic/Latino | 45 (28.0) | 47 (28.0) |
| ESKD N (%) | 114 (70.8) | 120 (71.9) |
| AKI N (%) | 47 (29.2) | 47 (28.1) |
| Diabetes N (%) | 84 (52.2) | 81 (48.5) |
| HTN N (%) | 142 (88.2) | 139 (83.2) |
| CVD N (%) | 55 (34.2) | 63 (37.8) |
| Obstructive sleep apnea N (%) | 37 (22.9) | 43 (25.7) |
| Sepsis N (%) | 35 (22.0) | 47 (28.0) |
| Circulatory shock N (%) | 22 (13.7) | 23 (13.8) |
| Admission to ICU N (%) | 33 (20.5) | 39 (23.4) |
| ICU patients receiving portable dialysis (count) | (n = 33) | (n = 39) |
| Age (yrs) | 60.8±13.2 | 56.0±16.8 |
| Female N (%) | 14 (42.4) | 14 (38.5) |
| Race/Ethnicity N (%) | ||
| White | 20 (60.6) | 19 (48.7) |
| Black | 8 (24.2) | 11 (28.2) |
| Hispanic/Latino | 5 (15.2) | 9 (23.1) |
| ESKD N (%) | 14 (42.4) | 23 (59.0) |
| AKI N (%) | 18 (54.5) | 16 (41.0) |
| Diabetes N (%) | 13 (39.4) | 17 (43.6) |
| HTN N (%) | 26 (78.8) | 32 (82.1) |
| CVD N (%) | 13 (39.4) | 16 (41.0) |
| Obstructive sleep apnea N (%) | 8 (24.2) | 10 (25.6) |
| Sepsis N (%) | 15 (45.5) | 16 (41.0) |
AKI, acute kidney injury; CVD, cardiovascular disease; ESKD, end stage kidney disease; HTN, hypertension; RBVM, relative blood volume monitoring; ICU, intensive care unit
All values are mean±SD.